| Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for unmet medical needs. Co. is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). In addition, Co. is developing a diagnostic device via a mobile device. Co. also has interests in certain other assets being developed by third parties including HT-005 for patients with lupus and potential product candidates being developed for the prevention of COVID-19. We show 15 historical shares outstanding datapoints in our HOTH shares outstanding history coverage, used to compute HOTH market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing HOTH market cap history over the course of time is important for investors
interested in comparing HOTH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of HOTH versus a peer is one thing; comparing
HOTH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like HOTH can fluctuate over the course of history.
With this page we aim to empower investors researching HOTH by allowing them to research the HOTH market cap history.